Merck KGaA (ETR:MRK)
Germany · Delayed Price · Currency is EUR 137.95
-0.10 (-0.07%)
Aug 21, 2026, 5:38 PM CET
Merck KGaA Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21,135 | 21,102 | 21,156 | 20,993 | 22,232 | 19,687 | |
Revenue Growth | -0.40% | -0.26% | 0.78% | -5.57% | 12.93% | 12.28% |
Cost of Revenue | 8,647 | 8,673 | 8,630 | 8,557 | 8,500 | 7,325 |
Gross Profit | 12,488 | 12,429 | 12,526 | 12,436 | 13,732 | 12,362 |
Selling, General & Admin | 6,082 | 5,946 | 5,794 | 5,674 | 5,989 | 5,458 |
Research & Development | 2,637 | 2,385 | 2,268 | 2,438 | 2,447 | 2,418 |
Other Operating Expenses | 56 | 177 | 243 | 486 | 325 | 177 |
Operating Expenses | 8,766 | 8,499 | 8,316 | 8,600 | 8,754 | 8,056 |
Operating Income | 3,722 | 3,930 | 4,210 | 3,836 | 4,978 | 4,306 |
Interest Expense | -410 | -326 | -229 | -260 | -196 | -245 |
Interest & Investment Income | 108 | 93 | 164 | 172 | 71 | 46 |
Currency Exchange Gain (Loss) | 196 | 196 | 52 | 51 | -109 | -34 |
Other Non Operating Income (Expenses) | 5 | 5 | 2 | 26 | -3 | 14 |
EBT Excluding Unusual Items | 3,621 | 3,898 | 4,199 | 3,825 | 4,741 | 4,087 |
Merger & Restructuring Charges | -297 | -297 | -272 | -384 | -199 | -141 |
Gain (Loss) on Sale of Assets | 157 | 157 | -3 | 132 | 45 | 63 |
Asset Writedown | -418 | -418 | -328 | -98 | -232 | -54 |
Legal Settlements | -54 | -54 | -48 | -1 | -6 | 8 |
Other Unusual Items | 22 | 22 | -11 | 10 | -61 | -39 |
Pretax Income | 3,031 | 3,308 | 3,537 | 3,484 | 4,288 | 3,924 |
Income Tax Expense | 647 | 693 | 751 | 650 | 948 | 859 |
Earnings From Continuing Operations | 2,384 | 2,615 | 2,786 | 2,834 | 3,340 | 3,065 |
Net Income to Company | 2,384 | 2,615 | 2,786 | 2,834 | 3,340 | 3,065 |
Minority Interest in Earnings | -14 | -7 | -9 | -10 | -14 | -10 |
Net Income | 2,370 | 2,608 | 2,777 | 2,824 | 3,326 | 3,055 |
Net Income to Common | 2,370 | 2,608 | 2,777 | 2,824 | 3,326 | 3,055 |
Net Income Growth | -17.22% | -6.09% | -1.66% | -15.09% | 8.87% | 53.75% |
Shares Outstanding (Basic) | 435 | 435 | 435 | 435 | 435 | 435 |
Shares Outstanding (Diluted) | 435 | 435 | 435 | 435 | 435 | 435 |
Shares Change | 0.00% | - | - | - | - | - |
EPS (Basic) | 5.45 | 6.00 | 6.39 | 6.50 | 7.65 | 7.03 |
EPS (Diluted) | 5.45 | 6.00 | 6.39 | 6.49 | 7.65 | 7.03 |
EPS Growth | -17.27% | -6.09% | -1.58% | -15.16% | 8.87% | 53.75% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2,724 | 2,347 | 2,884 | 1,977 | 2,728 | 3,550 |
Free Cash Flow Per Share | 6.27 | 5.40 | 6.63 | 4.55 | 6.27 | 8.16 |
Dividend Per Share | 2.200 | 2.200 | 2.200 | 2.200 | 2.200 | 1.850 |
Dividend Growth | 0% | 0% | 0% | 0% | 18.92% | 32.14% |
Gross Margin | 59.09% | 58.90% | 59.21% | 59.24% | 61.77% | 62.79% |
Operating Margin | 17.61% | 18.62% | 19.90% | 18.27% | 22.39% | 21.87% |
Profit Margin | 11.21% | 12.36% | 13.13% | 13.45% | 14.96% | 15.52% |
Free Cash Flow Margin | 12.89% | 11.12% | 13.63% | 9.42% | 12.27% | 18.03% |
EBITDA | 5,587 | 5,700 | 5,906 | 5,514 | 6,522 | 5,788 |
EBITDA Margin | 26.43% | 27.01% | 27.92% | 26.27% | 29.34% | 29.40% |
D&A For EBITDA | 1,865 | 1,770 | 1,696 | 1,678 | 1,544 | 1,482 |
EBIT | 3,722 | 3,930 | 4,210 | 3,836 | 4,978 | 4,306 |
EBIT Margin | 17.61% | 18.62% | 19.90% | 18.27% | 22.39% | 21.87% |
Effective Tax Rate | 21.35% | 20.95% | 21.23% | 18.66% | 22.11% | 21.89% |
Advertising Expenses | - | 556 | 526 | 515 | 476 | 461 |